The risk of urinary tract infections in patients with psoriasis on systemic medications in biobadaderm registry: a prospective cohort study
| dc.contributor.author | Sahuquillo-Torralba, Antonio | |
| dc.contributor.author | Ferran Farrés, Marta | |
| dc.contributor.author | García-Doval, Ignacio | |
| dc.contributor.author | Biobadaderm Study Group | |
| dc.date.accessioned | 2020-04-22T06:53:57Z | |
| dc.date.issued | 2020 | |
| dc.description.abstract | Biobadaderm is a multicenter prospective cohort that was created to evaluate the safety of systemic therapy for psoriasis patients.2 Once a year, reports are created. In 2018, a signal regarding symptomatic urinary tract infection (UTI) was detected. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Sahuquillo-Torralba A, Carretero G, Rivera R, Ferrándiz C, Daudén-Tello E, de la Cueva P, et al. The risk of urinary tract infections in patients with psoriasis on systemic medications in biobadaderm registry: a prospective cohort study. J Am Acad Dermatol. 2020 Mar; 82(3):738-41. DOI: 10.1016/j.jaad.2019.07.028 | |
| dc.identifier.doi | http://dx.doi.org/10.1016/j.jaad.2019.07.028 | |
| dc.identifier.issn | 0190-9622 | |
| dc.identifier.uri | http://hdl.handle.net/10230/44301 | |
| dc.language.iso | eng | |
| dc.publisher | Elsevier | |
| dc.rights | © Elsevier http://dx.doi.org/10.1016/j.jaad.2019.07.028 | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.subject.other | Aparell urinari -- Infeccions | |
| dc.subject.other | Psoriasi | |
| dc.title | The risk of urinary tract infections in patients with psoriasis on systemic medications in biobadaderm registry: a prospective cohort study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/acceptedVersion |
Files
Original bundle
1 - 1 of 1